Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06519422 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tranexamic Acid for Anaemia Trial

Study acronym: WOMAN-3
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from London School of Hygiene and Tropical Medicine

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modified
    • Recruitment opened
    • Trial sites expanded: 0 → 3 locations
    • Start date changed from estimate of Aug 2026 to Aug 10, 2026
    v3
  2. Start date: Sep 2025 to Aug 2026v2 Show 6 more changesShow less
    • Primary endpoint revised
    • Interventions: Matched placebo (Other), Tranexamic Acid 500 MG (Drug) to Placebo (Drug), Tranexamic Acid 500 MG (Drug)
    • Eligibility criteria expanded, about 21 words
    • Secondary endpoints: 10 to 15
    • Study description expanded, about 9 words
    • Collaborators: 1 to 7
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Anaemia is when the body does not have enough healthy red blood cells to carry oxygen. It is common in women because they lose blood every month during their periods. Anaemia can womwn make feel tired, weak, dizzy and out of breath. It can also make it harder to study, work or look after their family. If woman become pregnant with anaemia, it can cause problems for both mother and baby, such as early birth or heavy bleeding when giving birth. It is best to treat anaemia in young women well before they get pregnant. Doctors treat anaemia with iron and vitamins. But some people get side effects when taking iron tablets and so they stop taking them. Tranexamic acid (TXA) is a medicine used to treat heavy periods. The investigators of this study would like to find out if taking TXA with the usual iron and vitamin supplements is better at treating anaemia than taking iron and vitamin supplements alone. (Lay Summary)
Trial Details
NCT Number NCT06519422
Lead Sponsor London School of Hygiene and Tropical Medicine
Collaborators: University of Dar es Salaam, Tanzania (Mbeya College of Health and Allied Sciences), Coefficient Giving (Formerly Open Philanthropy), Versailles Saint-Quentin-en-Yvelines University, Shifa Tameer-e-Millat University, University College Hospital, Ibadan, The Jon Moulton Charity Trust, University of Edinburgh
Conditions
(from sponsor)		 Anaemia
Related terms Anemia, Hemorrhage, Iron Deficiencies
Enrollment 4,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov